Abstract
The cytochrome P450 isozymes in rat liver microsomes that catalyze the demethylenation of methylenedioxymethamphetamine enantiomers to the corresponding dihydroxymethamphetamine were characterized. Dihydroxymethamphetamine formation in liver microsomes from male Sprague- Dawley rats exhibited multienzyme kinetics, with K(m) values in the micromolar/millimolar range. The stereoselectivity [(+)-isomer versus (-)- isomer] varied from 0.78 to 1.94 after pretreatment of the rats with phenobarbital, 3-methylcholanthrene, pregnenolone-16α-carbonitrile, or pyrazole, suggesting that different isozymes participate in the reaction. The low-K(m) demethylenation was not induced by these compounds and was not inhibited by antibodies raised against CYP2C11. Liver microsomes from female Dark-Agouti rats, a strain genetically deficient in CYP2D1, exhibited demethylenation activities that were 9% of those in microsomes from male Sprague-Dawley rats. The low-K(m) demethylenation was also inhibited by CYP2D substrates such as sparteine, bufuralol, or desipramine and was almost completely inhibited by antibodies against P450 BTL, which belongs to the CYP2D family. The high-K(m) demethylenation activity was induced by phenobarbital and pregnenolone-16α-carbonitrile and the activity in both untreated and phenobarbital-induced microsomes was suppressed by anti-CYP2B1 IgG. Experiments with IgG raised against cytochrome b5 suggested that the hemoprotein contributed to the low-K(m) activity but not the high-K(m) activity. These results indicate that cytochrome P450 isozymes belonging to the CYP2D subfamily catalyze demethylenation with low K(m) values and that the reaction occurring with high K(m) values is likely to be mediated by members of the CYP2B family, but with the possible participation of other phenobarbital-inducible isoforms.
| Original language | English |
|---|---|
| Pages (from-to) | 359-365 |
| Number of pages | 7 |
| Journal | Molecular Pharmacology |
| Volume | 45 |
| Issue number | 2 |
| Publication status | Published - Feb 1994 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Pharmacology
Cite this
Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats. / Kumagai, Yoshito; Lin, Lena Y.; Hiratsuka, Akira; Narimatsu, Shizuo; Suzuki, Tokuji; Yamada, Hideyuki; Oguri, Kazuta; Yoshimura, Hidetoshi; Cho, Arthur K.
In: Molecular Pharmacology, Vol. 45, No. 2, 02.1994, p. 359-365.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats
AU - Kumagai, Yoshito
AU - Lin, Lena Y.
AU - Hiratsuka, Akira
AU - Narimatsu, Shizuo
AU - Suzuki, Tokuji
AU - Yamada, Hideyuki
AU - Oguri, Kazuta
AU - Yoshimura, Hidetoshi
AU - Cho, Arthur K.
PY - 1994/2
Y1 - 1994/2
N2 - The cytochrome P450 isozymes in rat liver microsomes that catalyze the demethylenation of methylenedioxymethamphetamine enantiomers to the corresponding dihydroxymethamphetamine were characterized. Dihydroxymethamphetamine formation in liver microsomes from male Sprague- Dawley rats exhibited multienzyme kinetics, with K(m) values in the micromolar/millimolar range. The stereoselectivity [(+)-isomer versus (-)- isomer] varied from 0.78 to 1.94 after pretreatment of the rats with phenobarbital, 3-methylcholanthrene, pregnenolone-16α-carbonitrile, or pyrazole, suggesting that different isozymes participate in the reaction. The low-K(m) demethylenation was not induced by these compounds and was not inhibited by antibodies raised against CYP2C11. Liver microsomes from female Dark-Agouti rats, a strain genetically deficient in CYP2D1, exhibited demethylenation activities that were 9% of those in microsomes from male Sprague-Dawley rats. The low-K(m) demethylenation was also inhibited by CYP2D substrates such as sparteine, bufuralol, or desipramine and was almost completely inhibited by antibodies against P450 BTL, which belongs to the CYP2D family. The high-K(m) demethylenation activity was induced by phenobarbital and pregnenolone-16α-carbonitrile and the activity in both untreated and phenobarbital-induced microsomes was suppressed by anti-CYP2B1 IgG. Experiments with IgG raised against cytochrome b5 suggested that the hemoprotein contributed to the low-K(m) activity but not the high-K(m) activity. These results indicate that cytochrome P450 isozymes belonging to the CYP2D subfamily catalyze demethylenation with low K(m) values and that the reaction occurring with high K(m) values is likely to be mediated by members of the CYP2B family, but with the possible participation of other phenobarbital-inducible isoforms.
AB - The cytochrome P450 isozymes in rat liver microsomes that catalyze the demethylenation of methylenedioxymethamphetamine enantiomers to the corresponding dihydroxymethamphetamine were characterized. Dihydroxymethamphetamine formation in liver microsomes from male Sprague- Dawley rats exhibited multienzyme kinetics, with K(m) values in the micromolar/millimolar range. The stereoselectivity [(+)-isomer versus (-)- isomer] varied from 0.78 to 1.94 after pretreatment of the rats with phenobarbital, 3-methylcholanthrene, pregnenolone-16α-carbonitrile, or pyrazole, suggesting that different isozymes participate in the reaction. The low-K(m) demethylenation was not induced by these compounds and was not inhibited by antibodies raised against CYP2C11. Liver microsomes from female Dark-Agouti rats, a strain genetically deficient in CYP2D1, exhibited demethylenation activities that were 9% of those in microsomes from male Sprague-Dawley rats. The low-K(m) demethylenation was also inhibited by CYP2D substrates such as sparteine, bufuralol, or desipramine and was almost completely inhibited by antibodies against P450 BTL, which belongs to the CYP2D family. The high-K(m) demethylenation activity was induced by phenobarbital and pregnenolone-16α-carbonitrile and the activity in both untreated and phenobarbital-induced microsomes was suppressed by anti-CYP2B1 IgG. Experiments with IgG raised against cytochrome b5 suggested that the hemoprotein contributed to the low-K(m) activity but not the high-K(m) activity. These results indicate that cytochrome P450 isozymes belonging to the CYP2D subfamily catalyze demethylenation with low K(m) values and that the reaction occurring with high K(m) values is likely to be mediated by members of the CYP2B family, but with the possible participation of other phenobarbital-inducible isoforms.
UR - http://www.scopus.com/inward/record.url?scp=0028069445&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028069445&partnerID=8YFLogxK
M3 - Article
C2 - 7906857
AN - SCOPUS:0028069445
VL - 45
SP - 359
EP - 365
JO - Molecular Pharmacology
JF - Molecular Pharmacology
SN - 0026-895X
IS - 2
ER -